Compounds Could Be New Class Of Cancer Drugs

Investigators have developed a group of chemical compounds -- the first selective inhibitors of the protein phospholipase D -- that could represent a new class of drugs for treating cancer. The new inhibitors block the invasive migration of breast cancer cells, supporting their further development as antimetastatic agents.

Read the whole article on Science Daily

More from Science Daily